A Pilot Study of SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) as Maintenance Therapy
Phase of Trial: Phase I
Latest Information Update: 02 May 2017
At a glance
- Drugs Guadecitabine (Primary) ; Cyclophosphamide; Tumour cell vaccine-GVAX
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 02 May 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 31 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 27 Oct 2013 New trial record